SCHEMBL16092241

SCHEMBL16092241

CC(C)c1c(-c2ccccc2F)[nH]c2c(C#N)cnn2c1=O

nearest known ligand 0.40

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ KDM5B Q9UGL1 3/20 0.40
▸ KDM5A P29375 10/20 0.38
▸ KDM6B O15054 1/20 0.38
▸ KDM5C P41229 1/20 0.38
▸ KDM5D Q9BY66 1/20 0.38
▸ KDM4C Q9H3R0 1/20 0.38
▸ PHF8 Q9UPP1 1/20 0.38
▸ KDM4D Q6B0I6 1/20 0.37
▸ GABRA1 P14867 1/20 0.36
▸ GABRG2 P18507 1/20 0.36
▸ GABRB3 P28472 1/20 0.36
▸ GABRA5 P31644 1/20 0.36
▸ GABRA3 P34903 1/20 0.36
▸ PLAT P00750 5/20 0.35
▸ ALDH1A1 P00352 1/20 0.34
▸ PDE10A Q9Y233 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16092249 0.84 KDM5A (0.47) KDM5BKDM5AKDM6BKDM5CKDM5D
SCHEMBL16091923 0.83 PTK6 (0.35) KDM4DPLAT
SCHEMBL16050372 0.83 KDM5A (0.35) KDM5BKDM5AKDM6BKDM5CKDM5D
SCHEMBL16092513 0.82 KDM5A (0.46) KDM5BKDM5AKDM6BKDM5CKDM5D
SCHEMBL16092238 0.82 CSNK2A1 (0.39) KDM5BKDM5AKDM6BKDM5CKDM5D
SCHEMBL16092509 0.82 KDM5A (0.38) KDM5BKDM5AKDM6BKDM5CKDM5D
SCHEMBL16092472 0.82 KDM5A (0.34) KDM5BKDM5AKDM6BKDM5CKDM5D
SCHEMBL16092434 0.81 PLAT (0.38) KDM5BKDM5AKDM6BKDM5CKDM5D
SCHEMBL16092255 0.81 KDM5B (0.42) KDM5BKDM5AKDM6BKDM5CKDM5D
SCHEMBL16092401 0.81 CREBBP (0.43) KDM5BKDM5AKDM6BKDM5CKDM5D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10035801-B2 Pyrazolo compounds and uses thereof GENENTECH, INC. (US) 2018-07-31 — — US disclosed
US-10035801-B2 Pyrazolo compounds and uses thereof GENENTECH, INC. (US) 2018-07-31 — — US disclosed
US-20160060267-A1 PYRAZOLO COMPOUNDS AND USES THEREOF GENENTECH, INC. (US) 2016-03-03 — — US disclosed
US-20160060267-A1 PYRAZOLO COMPOUNDS AND USES THEREOF GENENTECH, INC. (US) 2016-03-03 — — US disclosed
WO-2015135094-A1 THERAPEUTIC COMPOUNDS AND USES THEREOF GENENTECH, INC. (US) 2015-09-17 — — WO disclosed
WO-2014139326-A1 PYRAZOLO COMPOUNDS AND USES THEREOF GENENTECH, INC. (US) 2014-09-18 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10035801-B2 Pyrazolo compounds and uses thereof KDM5A, KDM5C, KDM5B KDM5B 3/4885KDM5A 1/4885KDM6B 11/4885
US-20160060267-A1 PYRAZOLO COMPOUNDS AND USES THEREOF KDM5A, KDM5C, KDM5B KDM5B 3/4885KDM5A 1/4885KDM6B 11/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback